Paul Grint
2017
In 2017, Paul Grint earned a total compensation of $500K as Chief Executive Officer at AmpliPhi Biosciences, a 1,011% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $50,000 |
|---|---|
| Option Awards | $154,163 |
| Salary | $277,083 |
| Other | $18,750 |
| Total | $499,996 |
Grint received $277.1K in salary, accounting for 55% of the total pay in 2017.
Grint also received $50K in non-equity incentive plan, $154.2K in option awards and $18.8K in other compensation.
Rankings
In 2017, Paul Grint's compensation ranked 11,874th out of 14,666 executives tracked by ExecPay. In other words, Grint earned more than 19.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,874 out of 14,666 | 19th |
Division Manufacturing | 4,678 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,710 out of 2,075 | 18th |
Industry group Drugs | 1,418 out of 1,731 | 18th |
Industry Biological Products, Except Diagnostic Substances | 251 out of 313 | 20th |
Source: SEC filing on November 9, 2018.
Grint's colleagues
We found five more compensation records of executives who worked with Paul Grint at AmpliPhi Biosciences in 2017.
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Michael Salka
AmpliPhi Biosciences
Chief Executive Officer
2017
Steve Martin
AmpliPhi Biosciences
Chief Financial Officer
2017
Paul Grint
AmpliPhi Biosciences